(Date of birth not provided)
![](https://tkafu.com/wp-content/uploads/2023/12/Tkafu-logo-1.png)
Skills
Team working skills
Leadership skills
Good computer skills
Certificates
-The 13 international congresses of the Jordanian ophthalmological society
-Participated in the 14th International Congress of the Middle East Africa Council of Ophthalmology 2019. Dead Sea, Jordan (September 5 – 8, 2019), (MEACO 2019)
-Completing the Basic & Clinical Science Course: Intraocular Inflammation & Uveitis (AACME). Amman, Jordan (December 18th, 2018)
-The optic, refraction & instruments examination in ophthalmology (international council of ophthalmology) 2019.
The visual sciences examination in ophthalmology (International council of ophthalmology) 2019
-MD, Ophthalmologist ,Council of Arab Health Ministers/the
Arab Board of Health Specialization Medical Specialized Board Jordan 2021
-ICO, International council of ophthalmology clinical ophthalmology
-ICO, International council of ophthalmology the Optic, Refraction and instruments examination in ophthalmology
ICO, International council of ophthalmology the visual sciences examination in ophthalmology
Languages
Education
Professional Experience
Covering the ophthalmology clinic for diabetes patients.
•
Examining of the eye along with multiple focal and pan retina.
Training centers during residency:
•
Eye specialty hospital
from 1/10/2020 – 30/9/2021 divided into 3 months on pediatric clinic, 3 months on cornea and refraction clinic and 2 months on Retina clinic.
•
Ibn Alhytham hospital
period of training 23/9/2017 – 30/9/2020.
•
King Hussein Cancer Center (KHCC)
in ocular oncologist department first of June 2021 – 31 Aug 2021.
•
National center for diabetes endocrinology and genetic
6-month duration during 2018 – 2019.
Monitoring and evaluation and ensuring the provision of quality, safe and efficacious pharmaceutical products, and services.
•
Directly responsible from medicines adverse event file mainly the Medicine not registered.
•
Field visits to hospital and inspection cases for adverse event.
•
Follow-up of adverse reactions of pharmaceutics through field visits
•
Determined and follow up of unregistered medication site effects.
•
Receiving and following up quality reports for incoming pharmaceutical products, evaluating them, and then taking the appropriate action